News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Gráfica donde se explican los gemelos digitales
The impact of digital twins on personalised medicine
Healthcare · Personalized medicine
Digital twins make it possible to simulate personalised clinical scenarios without intervening…
Firma del acuerdo de patrocinio entre la Real Federación Española de Fútbol (RFEF) y la compañía biofarmacéutica MSD
MSD becomes a healthcare partner of the Women's National Football Team
Healthcare
The aim of this alliance is to promote social awareness of human papillomavirus, the most common…
Equipo de Agomab
Asabys portfolio company Agomab Therapeutics completes Nasdaq IPO
Financing
Edificio de las oficinas de Oyzon Genomics
ORYZON to participate in upcoming events in February and March
International
Oryzon Genomics will be attending Bio-Neuroscience 2026, SmallCap Event 20th Edition, BIO-Europe…
Entrega de los Premios Natac en la sede del CSIC, en Madrid
Natac presents its National Awards for Research in Natural Products
Corporate
These awards recognize scientific excellence in the field of natural products and their…
Equipo de Pharmacelera
Pharmacelera raises €6 million to expand in U.S. and build out its high speed, high accuracy, deep tech drug discovery platform
Financing
The investment round was led by investment fund manager Heran Partners, with participation from…
Ivan Borrego (Founder & CEO de IB Corporate Growth) y Eloi Barceló (Business Development Director de Klinea)
Klinea strengthens its growth in the cosmetics industry through a strategic alliance with Ivan Borrego
Healthcare
The incorporation of advanced biotechnological assets—such as proteins, peptides, fermented…
EDIFICIO ORYZON
ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
Healthcare · Talento
Based in New Jersey (USA), to lead ORYZON’s CNS clinical development.
Miembros del equipo de Gyala Therapeutics
Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute leukemias with limited treatment options
Healthcare · Advanced therapies
The study has been initiated at Hospital La Fe in Valencia and Hospital Clínic Barcelona, two…